138 related articles for article (PubMed ID: 20348226)
41. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.
Ito H; Hirata Y; Adachi S; Tanaka M; Tsujino M; Koike A; Nogami A; Murumo F; Hiroe M
J Clin Invest; 1993 Jul; 92(1):398-403. PubMed ID: 8326007
[TBL] [Abstract][Full Text] [Related]
42. No involvement of the AT2-receptor in angiotensin II-enhanced sympathetic transmission in vitro.
Nap A; Balt JC; Pfaffendorf M; Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):100-5. PubMed ID: 12806592
[TBL] [Abstract][Full Text] [Related]
43. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin.
Chen L; McNeill JR; Wilson TW; Gopalakrishnan V
Hypertension; 1995 Jul; 26(1):83-8. PubMed ID: 7607737
[TBL] [Abstract][Full Text] [Related]
44. Role of endothelin in the control of peripheral vascular tone in human hypertension.
Taddei S; Virdis A; Ghiadoni L; Sudano I; Magagna A; Salvetti A
Heart Fail Rev; 2001 Dec; 6(4):277-85. PubMed ID: 11447302
[TBL] [Abstract][Full Text] [Related]
45. Exercise limits the production of endothelin in the coronary vasculature.
de Beer VJ; Bender SB; Taverne YJ; Gao F; Duncker DJ; Laughlin MH; Merkus D
Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1950-9. PubMed ID: 21317308
[TBL] [Abstract][Full Text] [Related]
46. ACE inhibitor and AT1 antagonist blockade of deformation-induced gene expression in the rabbit jugular vein through B2 receptor activation.
Lauth M; Cattaruzza M; Hecker M
Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):61-6. PubMed ID: 11145934
[TBL] [Abstract][Full Text] [Related]
47. Paradoxically enhanced endothelin-B receptor-mediated vasoconstriction in conscious old monkeys.
Asai K; Kudej RK; Takagi G; Kudej AB; Natividad F; Shen YT; Vatner DE; Vatner SF
Circulation; 2001 May; 103(19):2382-6. PubMed ID: 11352888
[TBL] [Abstract][Full Text] [Related]
48. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
[TBL] [Abstract][Full Text] [Related]
49. Analysis of responses to ANG IV: effects of PD-123319 and DuP-753 in the pulmonary circulation of the rat.
Nossaman BD; Feng CJ; Kaye AD; Kadowitz PJ
Am J Physiol; 1995 Feb; 268(2 Pt 1):L302-8. PubMed ID: 7864150
[TBL] [Abstract][Full Text] [Related]
50. Endothelin produces pulmonary vasoconstriction and systemic vasodilation.
Lippton HL; Hauth TA; Summer WR; Hyman AL
J Appl Physiol (1985); 1989 Feb; 66(2):1008-12. PubMed ID: 2565328
[TBL] [Abstract][Full Text] [Related]
51. Role of K(ATP)(+) channels in regulation of systemic, pulmonary, and coronary vasomotor tone in exercising swine.
Duncker DJ; Oei HH; Hu F; Stubenitsky R; Verdouw PD
Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H22-33. PubMed ID: 11123214
[TBL] [Abstract][Full Text] [Related]
52. Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries.
Batenburg WW; Garrelds IM; Bernasconi CC; Juillerat-Jeanneret L; van Kats JP; Saxena PR; Danser AH
Circulation; 2004 May; 109(19):2296-301. PubMed ID: 15117835
[TBL] [Abstract][Full Text] [Related]
53. Functional role of angiotensin II type 1 and 2 receptors in regulation of uterine blood flow in nonpregnant sheep.
Lambers DS; Greenberg SG; Clark KE
Am J Physiol Heart Circ Physiol; 2000 Feb; 278(2):H353-9. PubMed ID: 10666064
[TBL] [Abstract][Full Text] [Related]
54. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2003 Feb; 17(1):83-91. PubMed ID: 12588634
[TBL] [Abstract][Full Text] [Related]
55. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock.
Konrad D; Oldner A; Rossi P; Wanecek M; Rudehill A; Weitzberg E
Crit Care Med; 2004 May; 32(5):1192-9. PubMed ID: 15190972
[TBL] [Abstract][Full Text] [Related]
56. Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.
Fitzgerald RK; Oishi P; Ovadia B; Ross GA; Reinhartz O; Johengen MJ; Fineman JR
Pediatr Crit Care Med; 2004 Nov; 5(6):571-7. PubMed ID: 15530195
[TBL] [Abstract][Full Text] [Related]
57. Vasoconstrictor responses of coronary resistance arteries in exercise-trained pigs.
Laughlin MH; Muller JM
J Appl Physiol (1985); 1998 Mar; 84(3):884-9. PubMed ID: 9480947
[TBL] [Abstract][Full Text] [Related]
58. Effect of an AT1 receptor antagonist (CV-11974) on angiotensin II-induced cardiomyocyte hypertrophy in vitro.
Hirata Y; Kanno K; Eguchi S; Kano H
Blood Press Suppl; 1994; 5():84-8. PubMed ID: 7889209
[TBL] [Abstract][Full Text] [Related]
59. Regular aerobic exercise reduces endothelin-1-mediated vasoconstrictor tone in overweight and obese adults.
Dow CA; Stauffer BL; Brunjes DL; Greiner JJ; DeSouza CA
Exp Physiol; 2017 Sep; 102(9):1133-1142. PubMed ID: 28635124
[TBL] [Abstract][Full Text] [Related]
60. Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor.
Cannan CR; Burnett JC; Brandt RR; Lerman A
Circulation; 1995 Dec; 92(11):3312-7. PubMed ID: 7586319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
